[Reticuloendotherial system involvement in rheumatoid arthritis].
Takasaki
Yoshinari
Y
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications*; D005258:Felty Syndrome / Q000150:complications; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008107:Liver Diseases / Q000209:etiology*; D008199:Lymphadenitis / Q000209:etiology*; D012157:Mononuclear Phagocyte System; D013158:Splenic Diseases / Q000209:etiology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents